Vice President, FP&A at Moderna

Svetlana started her FP&A career back in 2008 with Vertex Pharmaceuticals. In her career, Svetlana was fortunate to apply herself in various Functional and Corporate FP&A roles (Bus Dev, Long Range Planning and valuation, Corporate P&L and Sales management, IR) and support both the Hep C and the Cystic Fibrosis launches. Svetlana also spent four years as an ex-pat in the UK, supporting the build-out of the International business at Vertex Pharmaceuticals.

Svetlana joined Moderna in September 2020, only three months before the COVID vaccine launch, and has built out core FP&A areas and processes at Moderna, including corporate and commercial FP&A and financial systems. Svetlana has witnessed Moderna’s Intelligent Transformation first-hand and continues to support the ongoing build-out of the company.

Svetlana resides in Massachusetts, USA, with her husband and two young kids.

LinkedIn profile: https://www.linkedin.com/in/svetlana-sigalova-aa78768/